BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 19893332)

  • 1. Cortisol and 3,4-methylenedioxymethamphetamine: neurohormonal aspects of bioenergetic stress in ecstasy users.
    Parrott AC
    Neuropsychobiology; 2009; 60(3-4):148-58. PubMed ID: 19893332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDMA, cortisol, and heightened stress in recreational ecstasy users.
    Parrott AC; Montgomery C; Wetherell MA; Downey LA; Stough C; Scholey AB
    Behav Pharmacol; 2014 Sep; 25(5-6):458-72. PubMed ID: 25014666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dance clubbing on MDMA and during abstinence from Ecstasy/MDMA: prospective neuroendocrine and psychobiological changes.
    Parrott AC; Lock J; Conner AC; Kissling C; Thome J
    Neuropsychobiology; 2008; 57(4):165-80. PubMed ID: 18654086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased cortisol levels in hair of recent Ecstasy/MDMA users.
    Parrott AC; Sands HR; Jones L; Clow A; Evans P; Downey LA; Stalder T
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):369-74. PubMed ID: 24333019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxytocin, cortisol and 3,4-methylenedioxymethamphetamine: neurohormonal aspects of recreational 'ecstasy'.
    Parrott AC
    Behav Pharmacol; 2016 Dec; 27(8):649-658. PubMed ID: 27681116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDMA and heightened cortisol: a neurohormonal perspective on the pregnancy outcomes of mothers used 'Ecstasy' during pregnancy.
    Parrott AC; Moore DG; Turner JJ; Goodwin J; Min MO; Singer LT
    Hum Psychopharmacol; 2014 Jan; 29(1):1-7. PubMed ID: 24424703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
    Parrott AC
    J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDMA and temperature: a review of the thermal effects of 'Ecstasy' in humans.
    Parrott AC
    Drug Alcohol Depend; 2012 Feb; 121(1-2):1-9. PubMed ID: 21924843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced memory skills and increased hair cortisol levels in recent Ecstasy/MDMA users: significant but independent neurocognitive and neurohormonal deficits.
    Downey LA; Sands H; Jones L; Clow A; Evans P; Stalder T; Parrott AC
    Hum Psychopharmacol; 2015 May; 30(3):199-207. PubMed ID: 25900184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.
    Parrott AC; Lasky J
    Psychopharmacology (Berl); 1998 Oct; 139(3):261-8. PubMed ID: 9784083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human psychobiology of MDMA or 'Ecstasy': an overview of 25 years of empirical research.
    Parrott AC
    Hum Psychopharmacol; 2013 Jul; 28(4):289-307. PubMed ID: 23881877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal functioning of the hypothalamic-pituitary-adrenal (HPA) axis and psychological distress in recreational ecstasy polydrug users.
    Wetherell MA; Montgomery C
    Psychopharmacology (Berl); 2014 Apr; 231(7):1365-75. PubMed ID: 24190587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syllogistic reasoning performance in MDMA (Ecstasy) users.
    Montgomery C; Fisk JE; Newcombe R; Wareing M; Murphy PN
    Exp Clin Psychopharmacol; 2005 May; 13(2):137-45. PubMed ID: 15943546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive performance and serotonergic function in users of ecstasy.
    Verkes RJ; Gijsman HJ; Pieters MS; Schoemaker RC; de Visser S; Kuijpers M; Pennings EJ; de Bruin D; Van de Wijngaart G; Van Gerven JM; Cohen AF
    Psychopharmacology (Berl); 2001 Jan; 153(2):196-202. PubMed ID: 11205419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis and Ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users.
    Parrott AC; Milani RM; Gouzoulis-Mayfrank E; Daumann J
    J Neural Transm (Vienna); 2007; 114(8):959-68. PubMed ID: 17520319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are there sex differences associated with the effects of ecstasy/3,4-methylenedioxymethamphetamine (MDMA)?
    Allott K; Redman J
    Neurosci Biobehav Rev; 2007; 31(3):327-47. PubMed ID: 17109962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits.
    Parrott AC; Lees A; Garnham NJ; Jones M; Wesnes K
    J Psychopharmacol; 1998; 12(1):79-83. PubMed ID: 9584971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDMA does not alter responses to the Trier Social Stress Test in humans.
    Bershad AK; Miller MA; de Wit H
    Psychopharmacology (Berl); 2017 Jul; 234(14):2159-2166. PubMed ID: 28432376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamic-pituitary-adrenal axis responses to stress in subjects with 3,4-methylenedioxy-methamphetamine ('ecstasy') use history: correlation with dopamine receptor sensitivity.
    Gerra G; Bassignana S; Zaimovic A; Moi G; Bussandri M; Caccavari R; Brambilla F; Molina E
    Psychiatry Res; 2003 Sep; 120(2):115-24. PubMed ID: 14527643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The harmful health effects of recreational ecstasy: a systematic review of observational evidence.
    Rogers G; Elston J; Garside R; Roome C; Taylor R; Younger P; Zawada A; Somerville M
    Health Technol Assess; 2009 Jan; 13(6):iii-iv, ix-xii, 1-315. PubMed ID: 19195429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.